Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
36.72 USD | +5.75% | +31.72% | +79.99% |
May. 24 | Mizuho Securities Starts Cartesian Therapeutics With Buy Rating | MT |
May. 22 | Cartesian Gets Regenerative Medicine Advanced Therapy Label for Myasthenia Gravis Drug Candidate | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+79.99% | 618M | |
+14.77% | 118B | |
+13.16% | 106B | |
-3.07% | 24.28B | |
+1.14% | 21.96B | |
-9.35% | 18.16B | |
-42.28% | 16.37B | |
-18.18% | 15.56B | |
+5.97% | 13.63B | |
+29.00% | 12.27B |
- Stock Market
- Equities
- RNAC Stock
- News Cartesian Therapeutics, Inc.
- Mizuho Securities Adjusts Selecta Biosciences Price Target to $4 From $5, Maintains Buy Rating